Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Epigenetic inactivation of TMS1/ASC in ovarian cancer.

Terasawa K, Sagae S, Toyota M, Tsukada K, Ogi K, Satoh A, Mita H, Imai K, Tokino T, Kudo R.

Clin Cancer Res. 2004 Mar 15;10(6):2000-6.

2.

Epigenetic regulation of ARHI in breast and ovarian cancer cells.

Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, Bast RC Jr.

Ann N Y Acad Sci. 2003 Mar;983:268-77. Review.

PMID:
12724231
3.

Epigenetic regulation of ASC/TMS1 expression: potential role in apoptosis and inflammasome function.

Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K.

Cell Mol Life Sci. 2014 May;71(10):1855-64. doi: 10.1007/s00018-013-1524-9. Epub 2013 Nov 28. Review.

PMID:
24287895
4.

Cancer epigenetics.

Momparler RL.

Oncogene. 2003 Sep 29;22(42):6479-83. Review.

PMID:
14528271
5.

TMS1/ASC: the cancer connection.

McConnell BB, Vertino PM.

Apoptosis. 2004 Jan;9(1):5-18. Review.

PMID:
14739594
6.
7.

DNA methylation patterns in cancer: novel prognostic indicators?

Frühwald MC.

Am J Pharmacogenomics. 2003;3(4):245-60. Review.

PMID:
12930158
8.

Epigenetic gene silencing in cancer.

Tycko B.

J Clin Invest. 2000 Feb;105(4):401-7. Review. No abstract available.

9.

FANCF methylation contributes to chemoselectivity in ovarian cancer.

Olopade OI, Wei M.

Cancer Cell. 2003 May;3(5):417-20. Review.

10.

A critical re-appraisal of BRCA1 methylation studies in ovarian cancer.

Senturk E, Cohen S, Dottino PR, Martignetti JA.

Gynecol Oncol. 2010 Nov;119(2):376-83. doi: 10.1016/j.ygyno.2010.07.026. Epub 2010 Aug 24. Review.

PMID:
20797776
11.

Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer.

Malek A, Schäfer R, Tchernitsa O.

Cancer Treat Rev. 2010 Feb;36(1):8-15. doi: 10.1016/j.ctrv.2009.10.005. Epub 2009 Nov 28. Review.

PMID:
19945796
12.

Epigenetics of ovarian cancer: from the lab to the clinic.

Asadollahi R, Hyde CA, Zhong XY.

Gynecol Oncol. 2010 Jul;118(1):81-7. doi: 10.1016/j.ygyno.2010.03.015. Epub 2010 Apr 24. Review.

PMID:
20421130
13.

Role of epigenomics in ovarian and endometrial cancers.

Balch C, Matei DE, Huang TH, Nephew KP.

Epigenomics. 2010 Jun;2(3):419-47. doi: 10.2217/epi.10.19. Review. Erratum in: Epigenomics. 2011 Apr;3(2):246.

14.

Tumor suppressor genes associated with drug resistance in ovarian cancer (review).

Yin F, Liu X, Li D, Wang Q, Zhang W, Li L.

Oncol Rep. 2013 Jul;30(1):3-10. doi: 10.3892/or.2013.2446. Epub 2013 May 9. Review.

PMID:
23660957
15.

On a possible epigenetic mechanism(s) of tumor cell heterogeneity. The role of DNA methylation.

Frost P, Kerbel RS.

Cancer Metastasis Rev. 1983;2(4):375-8. Review. No abstract available.

PMID:
6375860

Supplemental Content

Support Center